• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy.

作者信息

Hruska Keith A, Saab Georges, Chaudhary Lala R, Quinn Cheryl O, Lund Richard J, Surendran Kameswaran

机构信息

Department of Pediatrics, Washington University School of Medicine, St Louis, MO 63110, USA.

出版信息

Semin Nephrol. 2004 Jan;24(1):25-38. doi: 10.1053/j.semnephrol.2003.08.010.

DOI:10.1053/j.semnephrol.2003.08.010
PMID:14730507
Abstract

The relationship between bone and the kidney in renal osteodystrophy is a complex interplay of kidney to bone connections, bone to kidney connections, and cell to cell connections. In addition, such interactions have a profound effect on the vasculature. In this review, we discuss the role of the bone morphogenetic proteins (BMPs) in the skeleton, kidney, and vasculature. In addition, we propose that deficiencies of these BMPs seen in chronic kidney disease (CKD) result in decreased bone remodeling and a compensatory secondary hyperparathyroidism (high turnover state). Treatment of the hyperparathyroidism blocks this compensatory arm and thus decreased bone remodeling occurs (low turnover). We review animal models of CKD in which treatment with BMP-7 resulted in normalization of both high and low turnover states. Finally, we discuss vascular calcification as it relates to bone metabolism. We discuss the roles of BMP-7 and 2 other bone regulatory proteins, osteoprotegerin (OPG) and alpha2-HS glycoprotein (AHSG, human fetuin), in the human vasculature and their implications for vascular calcification.

摘要

相似文献

1
Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy.
Semin Nephrol. 2004 Jan;24(1):25-38. doi: 10.1053/j.semnephrol.2003.08.010.
2
Serum osteoprotegerin and renal osteodystrophy.血清骨保护素与肾性骨营养不良
Nephrol Dial Transplant. 2002 Feb;17(2):233-8. doi: 10.1093/ndt/17.2.233.
3
Osteoprotegerin and bone mineral density in hemodiafiltration patients.血液透析滤过患者的骨保护素与骨密度
Ren Fail. 2005;27(5):531-9. doi: 10.1080/08860220500198698.
4
The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.核因子-κB 受体激活剂配体抑制剂骨保护素在慢性肾功能不全和甲状旁腺功能亢进大鼠模型中是一种骨保护剂。
Calcif Tissue Int. 2006 Jan;78(1):35-44. doi: 10.1007/s00223-005-0161-1. Epub 2005 Dec 5.
5
Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.骨形态发生蛋白-7在肾脏骨中的作用及效应与慢性肾脏病中的骨-血管联系
Eur J Clin Invest. 2006 Aug;36 Suppl 2:43-50. doi: 10.1111/j.1365-2362.2006.01663.x.
6
Increased levels of osteoprotegerin in hemodialysis patients.血液透析患者骨保护素水平升高。
Clin Chem Lab Med. 2002 Oct;40(10):1019-23. doi: 10.1515/CCLM.2002.177.
7
[The bone-vasculature-axis interaction: new insights into the pathogenesis of vascular calcification.].[骨-血管轴相互作用:血管钙化发病机制的新见解。]
G Ital Nefrol. 2007 Sep-Oct;24(5):409-14.
8
Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients.骨保护素和甲状旁腺激素作为血液透析患者高转换型骨营养不良和骨矿化降低的标志物。
Am J Kidney Dis. 2002 Mar;39(3):580-6. doi: 10.1053/ajkd.2002.31409.
9
Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.激活素 A 信号的系统激活导致慢性肾脏病-矿物质骨代谢紊乱。
Int J Mol Sci. 2018 Aug 23;19(9):2490. doi: 10.3390/ijms19092490.
10
Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7.外源性骨形态发生蛋白-7治疗高转换型肾性骨营养不良小鼠模型
Kidney Int. 2002 Apr;61(4):1322-31. doi: 10.1046/j.1523-1755.2002.00258.x.

引用本文的文献

1
Data Mining and Network Pharmacology Analysis of Kidney-Tonifying Herbs on the Treatment of Renal Osteodystrophy Based on the Theory of "Kidney Governing Bones" in Traditional Chinese Medicine.基于中医“肾主骨”理论的补肾中药治疗肾性骨营养不良的数据挖掘与网络药理学分析
Evid Based Complement Alternat Med. 2022 Sep 30;2022:1116923. doi: 10.1155/2022/1116923. eCollection 2022.
2
New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy.肾性骨营养不良中骨转换的新型生化血清标志物
EJIFCC. 2004 Jun 17;15(2):23-28. eCollection 2004 Jun.
3
Ibandronate affects bone growth and mineralization in rats with normal and reduced renal function.
伊班膦酸盐对肾功能正常和降低的大鼠的骨骼生长和矿化有影响。
Pediatr Nephrol. 2011 Jan;26(1):111-7. doi: 10.1007/s00467-010-1660-5. Epub 2010 Oct 15.
4
Achievements and challenges in bioartificial kidney development.生物人工肾研发中的成就与挑战。
Fibrogenesis Tissue Repair. 2010 Aug 10;3:14. doi: 10.1186/1755-1536-3-14.
5
Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.BMP 拮抗剂 USAG-1 的缺失可改善进行性遗传性肾脏疾病 Alport 综合征小鼠模型的疾病。
J Clin Invest. 2010 Mar;120(3):768-77. doi: 10.1172/JCI39569. Epub 2010 Feb 8.
6
The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature.慢性肾脏病矿物质与骨异常中血管钙化的发病机制:骨骼与血管系统之间的联系
Semin Nephrol. 2009 Mar;29(2):156-65. doi: 10.1016/j.semnephrol.2009.01.008.
7
Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury.子宫致敏相关基因-1(USAG-1)是一种在肾脏中表达的新型骨形态发生蛋白拮抗剂,它会加速肾小管损伤。
J Clin Invest. 2006 Jan;116(1):70-9. doi: 10.1172/JCI25445. Epub 2005 Dec 8.
8
Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA.不对称二甲基精氨酸(ADMA)对基因表达的影响:深入了解血浆ADMA升高的病理生理意义。
PLoS Med. 2005 Oct;2(10):e264. doi: 10.1371/journal.pmed.0020264. Epub 2005 Oct 4.